Stryker: Strong Growth, With a Tariff Tailwind in the Profit Line

September 29, 2026 1 min read Premium comments

Courtesy of Stryker Corporation

orthopedicscash flow2Q26 earnings2Q26 salesStyker Corporation

Stryker supplied the scale and growth that make competitors pay attention: $6.6 billion of quarterly sales and a substantial increase in earnings. It also supplied an important footnote. Part of the profit improvement came from reversing previously recorded tariffs, not from selling another implant or instrument.

Join 13,000+ Subscribers

Get unlimited access to OTW reporting, member discussions, and the weekly newsletter.

13,000+ subscribers

Every OTW article, fully unlocked
Member comments and discussion
The weekly orthopedic business briefing

React: